 | • レポートコード：MRC2-11QY03844 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はモノクローナル抗体ベース製品のグローバル市場について調査・分析したレポートです。種類別（がん、自己免疫、炎症性、感染性、微生物性、ウイルス性疾患）市場規模、用途別（病院、研究、学術機関、診療所、診断研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別モノクローナル抗体ベース製品の競争状況、市場シェア ・世界のモノクローナル抗体ベース製品市場：種類別市場規模 2015年-2020年（がん、自己免疫、炎症性、感染性、微生物性、ウイルス性疾患） ・世界のモノクローナル抗体ベース製品市場：種類別市場規模予測 2021年-2026年（がん、自己免疫、炎症性、感染性、微生物性、ウイルス性疾患） ・世界のモノクローナル抗体ベース製品市場：用途別市場規模 2015年-2020年（病院、研究、学術機関、診療所、診断研究所） ・世界のモノクローナル抗体ベース製品市場：用途別市場規模予測 2021年-2026年（病院、研究、学術機関、診療所、診断研究所） ・北米のモノクローナル抗体ベース製品市場分析：米国、カナダ ・ヨーロッパのモノクローナル抗体ベース製品市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのモノクローナル抗体ベース製品市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のモノクローナル抗体ベース製品市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのモノクローナル抗体ベース製品市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Amgen、BD Biosciences、Biogen Idec、Biotest、CMC ICOS Biologices、Dendreon ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins. This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma.
Market Analysis and Insights: Global Monoclonal Antibody Based Products Market
The global Monoclonal Antibody Based Products market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Monoclonal Antibody Based Products Scope and Market Size
Monoclonal Antibody Based Products market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Monoclonal Antibody Based Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Amgen
BD Biosciences
Biogen Idec
Biotest
CMC ICOS Biologices
Dendreon
…
Market segment by Type, the product can be split into
Cancer
Autoimmune
Inflammatory
Infectious
Microbial
Viral Diseases
Market segment by Application, split into
Hospitals
Research
Academic Institutes
Clinics
Diagnostic Laboratories
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Monoclonal Antibody Based Products Revenue
1.4 Market by Type
1.4.1 Global Monoclonal Antibody Based Products Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cancer
1.4.3 Autoimmune
1.4.4 Inflammatory
1.4.5 Infectious
1.4.6 Microbial
1.4.7 Viral Diseases
1.5 Market by Application
1.5.1 Global Monoclonal Antibody Based Products Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Research
1.5.4 Academic Institutes
1.5.5 Clinics
1.5.6 Diagnostic Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Based Products Market Perspective (2015-2026)
2.2 Global Monoclonal Antibody Based Products Growth Trends by Regions
2.2.1 Monoclonal Antibody Based Products Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Monoclonal Antibody Based Products Historic Market Share by Regions (2015-2020)
2.2.3 Monoclonal Antibody Based Products Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Monoclonal Antibody Based Products Market Growth Strategy
2.3.6 Primary Interviews with Key Monoclonal Antibody Based Products Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Based Products Players by Market Size
3.1.1 Global Top Monoclonal Antibody Based Products Players by Revenue (2015-2020)
3.1.2 Global Monoclonal Antibody Based Products Revenue Market Share by Players (2015-2020)
3.1.3 Global Monoclonal Antibody Based Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Monoclonal Antibody Based Products Market Concentration Ratio
3.2.1 Global Monoclonal Antibody Based Products Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Based Products Revenue in 2019
3.3 Monoclonal Antibody Based Products Key Players Head office and Area Served
3.4 Key Players Monoclonal Antibody Based Products Product Solution and Service
3.5 Date of Enter into Monoclonal Antibody Based Products Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Monoclonal Antibody Based Products Historic Market Size by Type (2015-2020)
4.2 Global Monoclonal Antibody Based Products Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Monoclonal Antibody Based Products Market Size by Application (2015-2020)
5.2 Global Monoclonal Antibody Based Products Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Monoclonal Antibody Based Products Market Size (2015-2020)
6.2 Monoclonal Antibody Based Products Key Players in North America (2019-2020)
6.3 North America Monoclonal Antibody Based Products Market Size by Type (2015-2020)
6.4 North America Monoclonal Antibody Based Products Market Size by Application (2015-2020)
7 Europe
7.1 Europe Monoclonal Antibody Based Products Market Size (2015-2020)
7.2 Monoclonal Antibody Based Products Key Players in Europe (2019-2020)
7.3 Europe Monoclonal Antibody Based Products Market Size by Type (2015-2020)
7.4 Europe Monoclonal Antibody Based Products Market Size by Application (2015-2020)
8 China
8.1 China Monoclonal Antibody Based Products Market Size (2015-2020)
8.2 Monoclonal Antibody Based Products Key Players in China (2019-2020)
8.3 China Monoclonal Antibody Based Products Market Size by Type (2015-2020)
8.4 China Monoclonal Antibody Based Products Market Size by Application (2015-2020)
9 Japan
9.1 Japan Monoclonal Antibody Based Products Market Size (2015-2020)
9.2 Monoclonal Antibody Based Products Key Players in Japan (2019-2020)
9.3 Japan Monoclonal Antibody Based Products Market Size by Type (2015-2020)
9.4 Japan Monoclonal Antibody Based Products Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Monoclonal Antibody Based Products Market Size (2015-2020)
10.2 Monoclonal Antibody Based Products Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Monoclonal Antibody Based Products Market Size by Type (2015-2020)
10.4 Southeast Asia Monoclonal Antibody Based Products Market Size by Application (2015-2020)
11 India
11.1 India Monoclonal Antibody Based Products Market Size (2015-2020)
11.2 Monoclonal Antibody Based Products Key Players in India (2019-2020)
11.3 India Monoclonal Antibody Based Products Market Size by Type (2015-2020)
11.4 India Monoclonal Antibody Based Products Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Monoclonal Antibody Based Products Market Size (2015-2020)
12.2 Monoclonal Antibody Based Products Key Players in Central & South America (2019-2020)
12.3 Central & South America Monoclonal Antibody Based Products Market Size by Type (2015-2020)
12.4 Central & South America Monoclonal Antibody Based Products Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Amgen
13.1.1 Amgen Company Details
13.1.2 Amgen Business Overview
13.1.3 Amgen Monoclonal Antibody Based Products Introduction
13.1.4 Amgen Revenue in Monoclonal Antibody Based Products Business (2015-2020))
13.1.5 Amgen Recent Development
13.2 BD Biosciences
13.2.1 BD Biosciences Company Details
13.2.2 BD Biosciences Business Overview
13.2.3 BD Biosciences Monoclonal Antibody Based Products Introduction
13.2.4 BD Biosciences Revenue in Monoclonal Antibody Based Products Business (2015-2020)
13.2.5 BD Biosciences Recent Development
13.3 Biogen Idec
13.3.1 Biogen Idec Company Details
13.3.2 Biogen Idec Business Overview
13.3.3 Biogen Idec Monoclonal Antibody Based Products Introduction
13.3.4 Biogen Idec Revenue in Monoclonal Antibody Based Products Business (2015-2020)
13.3.5 Biogen Idec Recent Development
13.4 Biotest
13.4.1 Biotest Company Details
13.4.2 Biotest Business Overview
13.4.3 Biotest Monoclonal Antibody Based Products Introduction
13.4.4 Biotest Revenue in Monoclonal Antibody Based Products Business (2015-2020)
13.4.5 Biotest Recent Development
13.5 CMC ICOS Biologices
13.5.1 CMC ICOS Biologices Company Details
13.5.2 CMC ICOS Biologices Business Overview
13.5.3 CMC ICOS Biologices Monoclonal Antibody Based Products Introduction
13.5.4 CMC ICOS Biologices Revenue in Monoclonal Antibody Based Products Business (2015-2020)
13.5.5 CMC ICOS Biologices Recent Development
13.6 Dendreon
13.6.1 Dendreon Company Details
13.6.2 Dendreon Business Overview
13.6.3 Dendreon Monoclonal Antibody Based Products Introduction
13.6.4 Dendreon Revenue in Monoclonal Antibody Based Products Business (2015-2020)
13.6.5 Dendreon Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Monoclonal Antibody Based Products Key Market Segments
Table 2. Key Players Covered: Ranking by Monoclonal Antibody Based Products Revenue
Table 3. Ranking of Global Top Monoclonal Antibody Based Products Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Monoclonal Antibody Based Products Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cancer
Table 6. Key Players of Autoimmune
Table 7. Key Players of Inflammatory
Table 8. Key Players of Infectious
Table 9. Key Players of Microbial
Table 10. Key Players of Viral Diseases
Table 11. Global Monoclonal Antibody Based Products Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Monoclonal Antibody Based Products Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Monoclonal Antibody Based Products Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Monoclonal Antibody Based Products Market Share by Regions (2015-2020)
Table 15. Global Monoclonal Antibody Based Products Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Monoclonal Antibody Based Products Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Monoclonal Antibody Based Products Market Growth Strategy
Table 21. Main Points Interviewed from Key Monoclonal Antibody Based Products Players
Table 22. Global Monoclonal Antibody Based Products Revenue by Players (2015-2020) (Million US$)
Table 23. Global Monoclonal Antibody Based Products Market Share by Players (2015-2020)
Table 24. Global Top Monoclonal Antibody Based Products Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Based Products as of 2019)
Table 25. Global Monoclonal Antibody Based Products by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Monoclonal Antibody Based Products Product Solution and Service
Table 28. Date of Enter into Monoclonal Antibody Based Products Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Monoclonal Antibody Based Products Market Size by Type (2015-2020) (Million US$)
Table 31. Global Monoclonal Antibody Based Products Market Size Share by Type (2015-2020)
Table 32. Global Monoclonal Antibody Based Products Revenue Market Share by Type (2021-2026)
Table 33. Global Monoclonal Antibody Based Products Market Size Share by Application (2015-2020)
Table 34. Global Monoclonal Antibody Based Products Market Size by Application (2015-2020) (Million US$)
Table 35. Global Monoclonal Antibody Based Products Market Size Share by Application (2021-2026)
Table 36. North America Key Players Monoclonal Antibody Based Products Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Monoclonal Antibody Based Products Market Share (2019-2020)
Table 38. North America Monoclonal Antibody Based Products Market Size by Type (2015-2020) (Million US$)
Table 39. North America Monoclonal Antibody Based Products Market Share by Type (2015-2020)
Table 40. North America Monoclonal Antibody Based Products Market Size by Application (2015-2020) (Million US$)
Table 41. North America Monoclonal Antibody Based Products Market Share by Application (2015-2020)
Table 42. Europe Key Players Monoclonal Antibody Based Products Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Monoclonal Antibody Based Products Market Share (2019-2020)
Table 44. Europe Monoclonal Antibody Based Products Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Monoclonal Antibody Based Products Market Share by Type (2015-2020)
Table 46. Europe Monoclonal Antibody Based Products Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Monoclonal Antibody Based Products Market Share by Application (2015-2020)
Table 48. China Key Players Monoclonal Antibody Based Products Revenue (2019-2020) (Million US$)
Table 49. China Key Players Monoclonal Antibody Based Products Market Share (2019-2020)
Table 50. China Monoclonal Antibody Based Products Market Size by Type (2015-2020) (Million US$)
Table 51. China Monoclonal Antibody Based Products Market Share by Type (2015-2020)
Table 52. China Monoclonal Antibody Based Products Market Size by Application (2015-2020) (Million US$)
Table 53. China Monoclonal Antibody Based Products Market Share by Application (2015-2020)
Table 54. Japan Key Players Monoclonal Antibody Based Products Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Monoclonal Antibody Based Products Market Share (2019-2020)
Table 56. Japan Monoclonal Antibody Based Products Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Monoclonal Antibody Based Products Market Share by Type (2015-2020)
Table 58. Japan Monoclonal Antibody Based Products Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Monoclonal Antibody Based Products Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Monoclonal Antibody Based Products Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Monoclonal Antibody Based Products Market Share (2019-2020)
Table 62. Southeast Asia Monoclonal Antibody Based Products Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Monoclonal Antibody Based Products Market Share by Type (2015-2020)
Table 64. Southeast Asia Monoclonal Antibody Based Products Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Monoclonal Antibody Based Products Market Share by Application (2015-2020)
Table 66. India Key Players Monoclonal Antibody Based Products Revenue (2019-2020) (Million US$)
Table 67. India Key Players Monoclonal Antibody Based Products Market Share (2019-2020)
Table 68. India Monoclonal Antibody Based Products Market Size by Type (2015-2020) (Million US$)
Table 69. India Monoclonal Antibody Based Products Market Share by Type (2015-2020)
Table 70. India Monoclonal Antibody Based Products Market Size by Application (2015-2020) (Million US$)
Table 71. India Monoclonal Antibody Based Products Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Monoclonal Antibody Based Products Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Monoclonal Antibody Based Products Market Share (2019-2020)
Table 74. Central & South America Monoclonal Antibody Based Products Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Monoclonal Antibody Based Products Market Share by Type (2015-2020)
Table 76. Central & South America Monoclonal Antibody Based Products Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Monoclonal Antibody Based Products Market Share by Application (2015-2020)
Table 78. Amgen Company Details
Table 79. Amgen Business Overview
Table 80. Amgen Product
Table 81. Amgen Revenue in Monoclonal Antibody Based Products Business (2015-2020) (Million US$)
Table 82. Amgen Recent Development
Table 83. BD Biosciences Company Details
Table 84. BD Biosciences Business Overview
Table 85. BD Biosciences Product
Table 86. BD Biosciences Revenue in Monoclonal Antibody Based Products Business (2015-2020) (Million US$)
Table 87. BD Biosciences Recent Development
Table 88. Biogen Idec Company Details
Table 89. Biogen Idec Business Overview
Table 90. Biogen Idec Product
Table 91. Biogen Idec Revenue in Monoclonal Antibody Based Products Business (2015-2020) (Million US$)
Table 92. Biogen Idec Recent Development
Table 93. Biotest Company Details
Table 94. Biotest Business Overview
Table 95. Biotest Product
Table 96. Biotest Revenue in Monoclonal Antibody Based Products Business (2015-2020) (Million US$)
Table 97. Biotest Recent Development
Table 98. CMC ICOS Biologices Company Details
Table 99. CMC ICOS Biologices Business Overview
Table 100. CMC ICOS Biologices Product
Table 101. CMC ICOS Biologices Revenue in Monoclonal Antibody Based Products Business (2015-2020) (Million US$)
Table 102. CMC ICOS Biologices Recent Development
Table 103. Dendreon Company Details
Table 104. Dendreon Business Overview
Table 105. Dendreon Product
Table 106. Dendreon Revenue in Monoclonal Antibody Based Products Business (2015-2020) (Million US$)
Table 107. Dendreon Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibody Based Products Market Share by Type: 2020 VS 2026
Figure 2. Cancer Features
Figure 3. Autoimmune Features
Figure 4. Inflammatory Features
Figure 5. Infectious Features
Figure 6. Microbial Features
Figure 7. Viral Diseases Features
Figure 8. Global Monoclonal Antibody Based Products Market Share by Application: 2020 VS 2026
Figure 9. Hospitals Case Studies
Figure 10. Research Case Studies
Figure 11. Academic Institutes Case Studies
Figure 12. Clinics Case Studies
Figure 13. Diagnostic Laboratories Case Studies
Figure 14. Monoclonal Antibody Based Products Report Years Considered
Figure 15. Global Monoclonal Antibody Based Products Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Monoclonal Antibody Based Products Market Share by Regions: 2020 VS 2026
Figure 17. Global Monoclonal Antibody Based Products Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Monoclonal Antibody Based Products Market Share by Players in 2019
Figure 20. Global Top Monoclonal Antibody Based Products Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Based Products as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Monoclonal Antibody Based Products Revenue in 2019
Figure 22. North America Monoclonal Antibody Based Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Monoclonal Antibody Based Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Monoclonal Antibody Based Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Monoclonal Antibody Based Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Monoclonal Antibody Based Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Monoclonal Antibody Based Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Monoclonal Antibody Based Products Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed
モノクローナル抗体療法の世界市場（～2026年） Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal ant…- バイオシミラーモノクローナル抗体の世界市場（～2026年） Biosimilar monoclonal antibodies (mAbs) are complex, large proteins of the biosimilar family used by the immune system to identify and neutralize foreign bodies, such as bacteria, viruses, and others. These antibodies are normally administered in the treatment of diseases such as rheumatoid arthriti…
- モノクローナル抗体カスタムサービスの世界市場（～2026年） Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal ant…
- モノクローナル抗体サービスの世界市場（～2026年） Market Analysis and Insights: Global Monoclonal Antibody Service Market The global Monoclonal Antibody Service market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Monoclonal Antibody Service Scope and Market Size Monoclona…
- モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年） A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…